Skip to main content
. 2022 Oct 11;14:17590914221131446. doi: 10.1177/17590914221131446

Figure 4.

Figure 4.

Systemic ancrod administration reduces retinal fibrinogen accumulation in the diabetic murine retina. (A) Confocal images of retinas from 10-week nondiabetic and diabetic LPS-treated CX3CR1-WT and CX3CR1-KO mice display fibrinogen deposits (white) along CD31+ retinal vessels (red), which are not detectable in the ancrod-treated diabetic retina. (B) Quantification of fibrinogen in retinal tissues indicates elevated fibrinogen accumulation in retinas of nondiabetic and diabetic LPS-treated mice relative to naïve and ancrod-treated diabetic mice. n = 4–9 mice per group. Each point represents data from an individual mouse. * P <0.05, ** P <0.01, *** P <0.001, **** P <0.0001. Scale bars: 25 µm.